Atlas Trials

Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo

Clinical trial NCT03123016 · COMPLETED

Trial details

NCT number
NCT03123016
Sponsor
Icahn School of Medicine at Mount Sinai
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Vitiligo
Start date
2017-04-14
Primary completion
2019-08-05
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.